Diamond Therapeutics
Judy Blumstock has a diverse work experience in various roles and organizations. Judy is the Founder & CEO of Diamond Therapeutics since 2018. Prior to that, they worked at TIAP - Toronto Innovation Acceleration Partners, where they held the position of Executive Director Corporate Development from 2018 to 2021. Judy also served as the Senior Director of Strategic Planning at TIAP from 2009 to 2017. In addition, Judy worked as an Advisor at Thing Tank Labs from 2010 to 2015.
Judy Blumstock's education history includes pursuing a Master of Business Administration (MBA) degree in Finance, General from Columbia Business School. Additionally, they obtained a Bachelor of Science (BSc) degree in Biology, General from the University of Toronto.
This person is not in any teams
This person is not in any offices
Diamond Therapeutics
Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort — maximizingthe positive impact better drugs can have on the global mental health crisis.